Notice of 2026 Annual General Meeting Sydney, Australia, 7 October 2026: Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), attaches the following documents in relation to its 2026 Annual General Meeting: 1. Notice of 2026 Annual General Meeting (Notice); 2. Proxy Form; and 3. Access...
Recce Pharmaceuticals: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 43 pages · English
Release
Recce Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Recce Pharmaceuticals
- Notification of cessation of securities - RCE
- Resolutions under section 249N of the Corporations Act
- 2026 Annual General Meeting
- Results of General Meeting
- General Meeting Presentation
Later from Recce Pharmaceuticals
- Amendments to Debt Facility with Avenue Capital Group
- Notification regarding unquoted securities - RCE
- Independent Review of Indonesian Phase 3 R327G Trial Data
- License and Commercialisation Agreement in AUS/NZ for R327G
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals